AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets close in 6 hrs 16 mins

Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
235.12+1.13 (+0.48%)
As of 9:44AM EDT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close233.99
Bid232.20 x 100
Ask239.95 x 700
Day's Range235.02 - 236.15
52 Week Range184.50 - 279.98
Avg. Volume3,615,605
Market Cap78.82B
PE Ratio (TTM)6.16
Earnings DateN/A
Dividend & Yield2.80 (1.20%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters3 hours ago

    After Trump rally, equity investors move into healthcare, retailers

    High U.S. share prices are pushing Lipper Award-winning equity fund managers into the shares of beaten-down healthcare companies, retailers and emerging-market stocks that they say offer a greater chance for outsized gains. Fund managers from Poplar Forest, Parnassus Investments and Brandes Investment Partners are among the 2017 Lipper Award winners who are concerned about the high valuation of the benchmark S&P 500 index. "It's absolutely harder to find stocks at attractive valuations" now than it has been in the past few years, said Todd Ahlsten, lead portfolio manager of the Parnassus Core Equity fund.

  • The Most Attractive Value Stock There Is?
    GuruFocus.com15 hours ago

    The Most Attractive Value Stock There Is?

    These value investors love Allergan

  • Investopedia22 hours ago

    Insys Therapeutics' Syndros Gets Final DEA Rule

    The DEA has approved Syndros, an oral drug for chemotherapy and AIDs patients, as a Schedule II drug.